Cardiovascular disease and amyloidosis in phase III multiple myeloma trials: a systematic review of eligibility, screening and event reporting.

Henriques Peck O, McCoubrey A, Snowden JA, Wechalekar A, Travers J, Lees JS, Petrie MC, Lang NN

Open source

DOI: 10.1136/openhrt-2026-004240
Published: 2026 Sep 1
Container: Open heart
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/openhrt-2026-004240,
  title = {Cardiovascular disease and amyloidosis in phase III multiple myeloma trials: a systematic review of eligibility, screening and event reporting.},
  author = {Henriques Peck O and McCoubrey A and Snowden JA and Wechalekar A and Travers J and Lees JS and Petrie MC and Lang NN},
  year = {2026},
  journal = {Open heart},
  doi = {10.1136/openhrt-2026-004240},
  url = {https://doi.org/10.1136/openhrt-2026-004240}
}

RIS

TY  - JOUR
TI  - Cardiovascular disease and amyloidosis in phase III multiple myeloma trials: a systematic review of eligibility, screening and event reporting.
AU  - Henriques Peck O
AU  - McCoubrey A
AU  - Snowden JA
AU  - Wechalekar A
AU  - Travers J
AU  - Lees JS
AU  - Petrie MC
AU  - Lang NN
PY  - 2026
JO  - Open heart
DO  - 10.1136/openhrt-2026-004240
UR  - https://doi.org/10.1136/openhrt-2026-004240
ER  -

APA

O, H. P., A, M., JA, S., A, W., J, T., JS, L., MC, P., & NN, L. (2026). Cardiovascular disease and amyloidosis in phase III multiple myeloma trials: a systematic review of eligibility, screening and event reporting.. Open heart. https://doi.org/10.1136/openhrt-2026-004240

Source records

pubmed · retrieved 2026-09-25T20:06:36.240Z
europe-pmc · retrieved 2026-09-25T20:06:36.248Z
doaj · retrieved 2026-09-25T20:06:36.248Z